Sophie de Carné Trécesson
Sophie de Carné Trécesson
Other namesSophie de Carné, Sophie de Carne
Verified email at
Cited by
Cited by
Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA
MA Coelho, S de Carné Trécesson, S Rana, D Zecchin, C Moore, ...
Immunity 47 (6), 1083-1099. e6, 2017
The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition
S Courapied, H Sellier, S de Carné Trécesson, A Vigneron, AC Bernard, ...
Journal of Biological Chemistry 285 (35), 26765-26778, 2010
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ...
Nature 616 (7957), 563-573, 2023
Tight sequestration of BH3 proteins by BCL-xL at subcellular membranes contributes to apoptotic resistance
J Pécot, L Maillet, J Le Pen, C Vuillier, S de Carné Trécesson, A Fétiveau, ...
Cell reports 17 (12), 3347-3358, 2016
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
A Basseville, L Preisser, S de Carné Trécesson, M Boisdron-Celle, ...
Molecular cancer 10, 1-12, 2011
Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins
S de Carné Trécesson, Y Guillemin, A Bélanger, AC Bernard, L Preisser, ...
Journal of Biological Chemistry 286 (15), 12825-12838, 2011
Genomic–transcriptomic evolution in lung cancer and metastasis
C Martínez-Ruiz, JRM Black, C Puttick, MS Hill, J Demeulemeester, ...
Nature 616 (7957), 543-552, 2023
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
B Jonchère, A Vétillard, B Toutain, D Lam, AC Bernard, C Henry, ...
Oncotarget 6 (1), 409, 2015
BCL-XL directly modulates RAS signalling to favour cancer cell stemness
S Carné Trécesson, F Souazé, A Basseville, AC Bernard, J Pécot, ...
Nature Communications 8 (1), 1123, 2017
Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival
F Braun, S de Carné Trécesson, J Bertin-Ciftci, P Juin
Cell Cycle 12 (18), 2937-2947, 2013
An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations
J Boumelha, S de Carné Trécesson, EK Law, P Romero-Clavijo, ...
Cancer research 82 (19), 3435-3448, 2022
Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin)
A Breiman, MDL Robles, S de Carné Trécesson, K Echasserieau, ...
Oncotarget 7 (12), 14064, 2016
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
P East, GP Kelly, D Biswas, M Marani, DC Hancock, T Creasy, ...
Nature communications 13 (1), 5632, 2022
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
DR Caswell, P Gui, MK Mayekar, EK Law, O Pich, C Bailey, J Boumelha, ...
Nature Genetics 56 (1), 60-73, 2024
Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold …
P Anastasiou, C Moore, S Rana, A de Castro, M Tomaschko, J Boumelha, ...
bioRxiv, 2024.01. 15.575765, 2024
In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer
J Boumelha, A de Castro, N Bah, H Cha, S de Carné Trécesson, S Rana, ...
bioRxiv, 2023.04. 13.536740, 2023
Oncogène RAS et Cancer Colorectal: Étude de la Réponse au Stress Oncogénique et de l'Échappement à la Sénescence
S de Carné Trécesson
Université d'Angers, 2010
RAS orchestrates an increase of interstitial adenosine in lung adenocarcinoma to promote immune evasion
S de Carné Trécesson, J Boumhela, C Moore, D Caswell, ...
European Journal of Cancer 138, S20-S21, 2020
The system can't perform the operation now. Try again later.
Articles 1–18